Jersey City, New Jersey Clinical Trials

A listing of Jersey City, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 382 clinical trials
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

Memorial Sloan Kettering Cancer Center
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
Families Children and Teachers Thriving Together

The current study examines the impact of ParentCorps in high-poverty district schools in New York City (NYC). The study is conducted within the context of the NYC Department of Education (DOE) Pre-K Thrive initiative. As part of this initiative, the Center for Early Childhood Health and Development (CEHD) at NYU …

cehd
inspire
NYU Langone Health
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
UAT Study

Bowen Test Study Overview

Formal Test Site - NY
 (5.1 away) Contact site
  • 0 views
  • 09 May, 2025
  • +7 other locations
None

Memorial Sloan Kettering Cancer Center
 (6.3 away) Contact site
  • 0 views
  • 19 May, 2025
  • +19 other locations
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease  

The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).

alzheimer's disease
Weill Cornell Medicine
 (6.3 away)
  • 0 views
  • 09 May, 2025
  • +2 other locations
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System - INFINITE-US

Prospective, non-randomized, multicenter pre-market early feasibility study (EFS) to evaluate subjects treated with the BlueLeaf System for the treatment of symptomatic CVI of the lower extremity

NYU Langone Medical Center
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Dynamically Tailored Behavioral Interventions in Diabetes

In this project, the investigators will evaluate the efficacy of a novel approach to personalizing behavioral interventions for self-management of type 2 diabetes (T2DM) to individuals' behavioral and glycemic profiles discovered using computational learning and self-monitoring data. This study is a two-arm randomized controlled trial with n=280 participants recruited from …

self monitoring
behavior modification
Clinical Directors Network
 (4.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Accelerometer Sensing for Micra AV Study

The purpose of the AccelAV Study is to characterize chronic AV synchrony in subjects implanted with MicraTM AV device. This study will be conducted upon market approval of the MicraTM AV Transcatheter Pacing System.

atrioventricular block
NYU Langone Medical Center
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Yoga for Anxiety in Adults

The purpose of this study is to investigate the effect of a telerehabilitation-yoga intervention delivered remotely via videoconferencing on adults with Parkinson's Disease and anxiety symptoms.

anxiety
anxiety symptoms
parkinson's disease
Rutgers University
 (6.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.

castration-resistant prostate cancer
metastatic disease
measurable disease
metastatic hormone refractory prostate cancer
metastasis
Memorial Sloan Kettering Cancer Center
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations